Delivery Order SPE2DB20D1100-SPE2DB25FD6K7
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $12,014 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 180 mg vials of the drug TRODELVY. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide....
- This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $9,010.50 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), to provide the pharmaceutical product TRODELVY 180 MG VIALS. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trodelvy 180 mg vials. The contract has a ceiling value of $6,389.72 and a performance period ending on May 22, 2025. It is a firm fixed-price contract, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,584.58 firm fixed-price delivery order is for the supply of TRODELVY 180MG VIAL 1S medical products, with a completion date of July 3, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,010.50 to Amerisourcebergen Drug Corp, the prime contractor, to provide 180 mg vials of the pharmaceutical drug TRODELVY. The contract has a completion date of March 7, 2024 and was awarded on February 14, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical in the amount of $14,587.30 to supply 180 mg vials of TRODELVY, an oncology medication. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by November 22, 2023. This order was awarded against an indefinite-delivery contract held by Amerisourcebergen with no set-aside designation specified. As a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $15,017.50 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide TRODELVY 180 MG VIALS. The contract has a completion date of February 15, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $18,021.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TRODELVY 180 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the supply of TRODELVY 180 MG VIALS, a pharmaceutical product, with a ceiling value of $12,779.44 and a completion date of August 7, 2025. The contract is a firm fixed-price delivery order, and it is not a set-aside contract. AmerisourceBergen Drug Corp has an Indefinite Delivery...
- This is a Firm Fixed Price delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, for the procurement of TRODELVY 180 MG VIALS. The contract has a ceiling value of $6,389.72 and a period of performance through June 20, 2025. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC) with...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6K7Delivery Order
The Defense Logistics Agency awarded a $9,584.58 delivery order to AmerisourceBergen Drug Corp for the supply of Trodelvy 180 mg vials, with a completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order reflects the pharmaceutical distributor's ongoing role as a critical medical supplier to federal healthcare systems. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle provides a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad spectrum of brand-name and generic medications, specialty drugs, vaccines, and medical supplies to support military healthcare programs worldwide. The contract serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a foundational vendor within the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 7/25/25 |